In today’s video, we discuss something subjective – are video game remasters good or bad? And...
Big Pharma Mixes Sim And Puzzle Elements With Ethical Connotations
Publisher Positech Games will be handling another title by the name of Big Pharma, which is headed to PC in the summer of 2015. It will mix ethical decisions in a blend of builder simulations and puzzle elements.
Players take charge of a pharmaceutical conglomerate that tries to earn revenue by producing cures to sell. This design is set to leverage the will to benefit the world against the desire for monetary gain.
To produce the most effective products, you’ll need to research new items and provide better treatments than the opposition, for a better profit margin. From the early days of spitting out generic brands, you’ll be able to eventually move into world-changing materials.
Another part to take into consideration in Big Pharma is production limitations. Factories need to optimally run with the proper equipment in the right place to produce as much stock as possible.
Here, the game offers an intriguing puzzle dynamic with conveyor belts linking production, mixing and testing equipment together in a complex web of mechanical engineering. More efficient plants will be able to withstand more competition.
Developer Twice Circled uses a few key inspirations from other known simulation games that have hit it big. Tim Wicksteed of Twice Circled comments:
If you took the ethical decision making from Prison Architect, the mechanics from Roller Coaster Tycoon but with the theme of Theme Hospital then you might be getting close to what Big Pharma is all about.
Moreover, the developer stresses that, while there is a certain artsy feel to the creation design paired with moral ramifications, the main goal of Big Pharma is still for it to be fun.
Big Pharma raises a topical question whether pharmaceutical corporations are in it for altruistic reasons or for financial wealth more than anything. Just recently, Bayer CEO Marijn Dekkers revealed their company’s evil intention, saying that the company doesn’t produce cures for poor people, but for people who can afford it.
Pricing is said to be “premium,” which relates to the business model Positech Games upholds for its titles, usually set between €15 and €30. Publisher mastermind Cliff Harris is strongly against the devaluation of PC titles and instead offers deep and intricately designed titles like Democracy 3 and Redshirt.
If you’re interested in playing Big Pharma early, you’ll be able to do so at EGX London this week.